// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) score: the first validated combined index predictive of future weight loss in systemic sclerosis

Gianluca Bagnato - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Physician-patient interaction and medication adherence in lupus nephritis

Sofia Georgopoulou - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

End stage renal disease

N/A

Mortality in granulomatosis with polyangiitis: a population-based case control study

Fiona A Pearce - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Wegener's granulomatosis

N/A

Low level detection of CTD-associated autoantibodies in patients with idiopathic pulmonary fibrosis confirms this as a robust phenotype when diagnosed on clinical grounds alone

Caroline V Cotton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

The immunopathogenesis of juvenile-onset SLE could be associated with altered immune cell plasma membrane lipids and lipoprotein metabolism

George Robinson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Value for money: a biologic pharmacist clinic

Amit Sahni - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Complex immunophenotyping stratifies patients with primary and secondary Sjögren’s syndrome into distinct clinically relevant groups with potential therapeutic implications

Nicolyn L Thompson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

N/A

IL-17+ CD8+ T cells are a pro-inflammatory tissue resident population enriched in joints of patients with spondyloarthritis

Kathryn J A Steel - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

Efficacy and safety of ixekizumab at week 24 in biologic experienced patients with active psoriatic arthritis summary results

Helena Marzo-Ortega - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

LY2439821

Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis

Elizabeth M A Hensor - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Infliximab

The incidence of adult idiopathic inflammatory myopathies at a UK specialist neuromuscular centre: a ten-year epidemiology study

Matthew J S Parker - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic inflammatory myopathies

N/A

Predicting remission from one year following initial presentation in a multicentre inception cohort of patients with juvenile idiopathic arthritis

Stephanie Shoop-Worrall - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Cost-effectiveness of a clinical nurse specialist performing targeted musculoskeletal ultrasound in the rheumatology clinic

Paul Davies - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Let’s talk about sex: an occupational therapy clinical evaluation about the importance of sexual intimacy issues in the treatment of patients with persistent pain

Charlie Ewer-Smith - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

11beta-hydroxysteroid dehydrogenase type 1 regulates the suppression of inflammation, joint destruction and systemic bone loss in a model of chronic inflammation

Rowan S Hardy - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Twin-reversed arterial perfusion

Glucocorticoid

The antioxidant EUK-134 mitigates ER stress-induced mitochondrial dysfunction in human skeletal muscle cells

Max Lyon - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Superoxide dismutase

Reducing Arthritis Fatigue: clinical Teams (RAFT) using a cognitive-behavioural approach: a randomised controlled trial

Sarah Hewlett - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Impact of biologic therapy on work in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis (BSRBR-AS) and meta-analysis

Joanna Shim - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

N/A

Hospitalisation trends for systemic lupus erythematosus and rheumatoid arthritis in England from 1998 to 2014

Jennifer R Hannah - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Successful treatment of Epstein Barr virus-triggered macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis

Owen Cronin - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Macrophage activation syndrome

N/A

Copyright © 2026. QuantiNova All rights reserved